Aligning interests with shareholders through stock-price-linked stock options
First written in FY2016. 23 of 25 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.
106 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Exercised - 65,500 Expired - 443,000 Outstanding and unexercised 70,000 -」
Of the 2019 stock options, 65,500 shares were exercised and 443,000 shares expired. The disclosure shows the exercise of rights under the share-price- and performance-linked compensation scheme and changes in the outstanding balance. - FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 (Note) 65,500 39,783,552 53 9,317 53 236 (Note) Increase due to the exercise of share acquisition rights.」
The number of shares increased by 65,500 through the exercise of share acquisition rights during the interim consolidated accounting period. Exercises of stock options linked to the share price and business performance have continued. - FY2025AdvancedAnnual report
「Common shares 15,500 shares」
The number of common shares increased by 15,500 through the exercise of share acquisition rights during the fiscal year. Exercises of stock options linked to the share price and business performance have continued. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 (Note) 8,000 39,710,552 6 9,257 6 176 (Note) Increase due to the exercise of share acquisition rights.」
During the interim consolidated accounting period, the number of shares increased by 8,000 through the exercise of share acquisition rights, and exercises of stock options linked to the share price and business performance have continued. - FY2024AdvancedAnnual report
「1 April 2023–31 March 2024 197,400」
The number of common shares increased by 197,400 during the fiscal year through the exercise of share acquisition rights, and the exercise of stock options linked to the share price and business performance continued. - FY2024-Q2AdvancedAnnual report
「1 July 2023–31 August 2023 (Note) 1 115,000 39,635,052 100 9,194 100 2,802 (Note) 1. Increase due to the exercise of share acquisition rights. 3. Between 1 October 2023 and 31 October 2023, the total number of shares issued and outstanding increased by 5,000 through the exercise of share acquisition rights, while capital stock and capital surplus each increased by ¥4 million.」
Through the exercise of share acquisition rights, 115,000 shares were issued between July and August and 5,000 shares were issued in September. An additional increase of 5,000 shares by the filing date was disclosed. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 (Note) 1 14,900 39,520,052 12 9,094 12 2,702 (Note) 1. Increase due to the exercise of share acquisition rights.」
The total number of shares issued and outstanding increased by 14,900 during the quarter through the exercise of share acquisition rights. The exercise of stock options linked to the share price and business performance has continued. - FY2023-Q3AdvancedAnnual report
「1 October 2022–31 December 2022 (Note) 1 66,000 42,473,952 55 9,033 55 2,641 (Note) 1. Increase due to the exercise of share acquisition rights. 2. Between 1 January 2023 and 31 January 2023, the total number of shares issued and outstanding increased by 42,000 through the exercise of share acquisition rights, while capital stock and capital surplus each increased by ¥36 million.」
The number of shares increased by 66,000 during the third-quarter accounting period through the exercise of share acquisition rights, and an additional increase of 42,000 shares by the filing date was disclosed. The exercise of stock options linked to the share price and business performance has continued. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note) 1 2,000 42,407,952 1 8,977 1 2,585 (Note) 1. Increase due to the exercise of share acquisition rights. 2. Between 1 October 2022 and 31 October 2022, the total number of shares issued and outstanding increased by 12,000 through the exercise of share acquisition rights, while capital stock and capital surplus each increased by ¥9 million.」
The number of shares increased by 2,000 during the second-quarter accounting period through the exercise of share acquisition rights, and an additional increase of 12,000 shares by the filing date was disclosed. - FY2021AdvancedAnnual report
「Common shares: 7,000 shares」
The number of shares increased by 7,000 during the fiscal year through the exercise of share acquisition rights, and the exercise of stock options linked to the share price and business performance has continued. - FY2021-Q3AdvancedAnnual report
「1 October 2020–31 December 2020 6,500 (Note) 1. Increase due to the exercise of share acquisition rights.」
The number of shares increased by 6,500 during the third-quarter accounting period through the exercise of share acquisition rights, and the exercise of stock options linked to the share price and business performance has continued. - FY2021-Q2AdvancedAnnual report
「1 July 2020–30 September 2020 (Note) Increase due to the exercise of share acquisition rights.」
The total number of shares issued and outstanding increased by 500 during the second-quarter accounting period through the exercise of share acquisition rights, and the exercise of the existing stock options has continued. - FY2020RestatedAnnual report
「Company directors 5 people Directors of affiliated companies 16 people Employees of the company and affiliated companies 478 people Number of share acquisition rights 7,185 units Class, details and number of shares underlying the share acquisition rights Common shares 718,500 shares」
The annual disclosure confirms the terms of the 2019 stock option grant and the compensation policy of sharing the risk of a share-price decline with shareholders. - FY2020-Q2AdvancedAnnual report
「Resolution date 28 August 2019 Category and number of eligible persons (people) Company directors 5 Directors of affiliated companies 16 Employees of the company and affiliated companies 478 Number of share acquisition rights (units) * 7,215 Class, details and number of shares underlying the share acquisition rights (shares) * Common shares 721,500 Exercise period for the share acquisition rights * From 29 August 2021 To 28 August 2025」
The company newly granted 7,215 share acquisition rights covering 721,500 shares, with an exercise period set, for the purpose of linking compensation to the share price and business performance. - FY2020-Q1AdvancedAnnual report
「1 April 2019–30 June 2019 (Note) 46,900 43,929,488 24 8,969 24 2,577 (Note) Increase due to the exercise of share acquisition rights.」
The number of shares increased by 46,900 during the first quarter through the exercise of share acquisition rights, and the exercise of stock options has continued. - FY2019AdvancedAnnual report
「For the 2018 stock options, the company disclosed 83,500 shares granted before exercise, 21,900 shares exercised during the fiscal year and 83,000 unexercised shares remaining.」
For the stock options intended to align interests with shareholders, the company disclosed specific results for the 2018 grant and the exercise of 21,900 shares during the fiscal year. - FY2019-Q3AdvancedAnnual report
「1 October 2018–31 December 2018 (Note) 7,500 43,878,688 3 8,942 3 2,550 (Note) Increase due to the exercise of share acquisition rights.」
The total number of shares issued and outstanding increased by 7,500 during the third-quarter accounting period through the exercise of share acquisition rights, and the exercise of stock options has continued. - FY2019-Q2AdvancedAnnual report
「Number of share acquisition rights (units) * 835 Class, details and number of shares underlying the share acquisition rights (shares) * Common shares 83,500 Exercise period for the share acquisition rights * From 30 August 2020 To 29 August 2024」
For the share acquisition rights approved on 29 August 2018, the company issued 835 rights covering 83,500 shares and set an exercise period from 30 August 2020 to 29 August 2024. - FY2019-Q1AdvancedAnnual report
「1 April 2018–30 June 2018 9,000 48,358,700 4 8,937 4 2,545 (Note) 1. Increase due to the exercise of share acquisition rights. 2. Between 1 July 2018 and 31 July 2018, the total number of shares issued and outstanding increased by 1,500 through the exercise of share acquisition rights, while capital stock and capital surplus each increased by ¥0.7 million.」
The number of shares issued and outstanding increased by 9,000 during the quarter through the exercise of share acquisition rights and by a further 1,500 shares in July before the filing date, indicating that the existing stock options continue to be exercised. - FY2018-Q3AdvancedAnnual report
「1 October 2017–31 December 2017 (Note) 1. Increase due to the exercise of share acquisition rights.」
The total number of shares issued and outstanding increased by 20,500 during the third-quarter accounting period through the exercise of share acquisition rights, disclosing that the existing stock options had been exercised. - FY2018-Q2AdvancedAnnual report
「The share acquisition rights issued during the second-quarter accounting period are as follows. Number of share acquisition rights (units) 5,625 Number of shares underlying the share acquisition rights (shares) 562,500 Exercise period for the share acquisition rights From 30 August 2019 To 29 August 2023」
The company issued 5,625 share acquisition rights covering 562,500 shares under stock options linked to the share price and business performance, and set the exercise period. - FY2017AdvancedAnnual report
「The stock options existing during the consolidated fiscal year are covered, and the number of stock options is presented on a share-equivalent basis.」
In addition to an increase of 47,000 shares through the exercise of stock options during the fiscal year, the company disclosed 70,500 unvested shares under the 2016 stock options. - FY2017-Q3AdvancedAnnual report
「1 October 2016–31 December 2016 (Note) 1. Increase due to the exercise of share acquisition rights.」
The total number of shares issued and outstanding increased by 2,500 during the third-quarter accounting period through the exercise of share acquisition rights, and the exercise of the existing stock options was disclosed. - FY2017-Q2AdvancedAnnual report
「The share acquisition rights issued during the second-quarter accounting period are as follows. Number of share acquisition rights (units) 730 Number of shares underlying the share acquisition rights (shares) 73,000 Exercise period for the share acquisition rights From 30 August 2018 To 29 August 2022」
The company issued 730 share acquisition rights covering 73,000 shares under stock options linked to the share price and business performance. - FY2016First statedAnnual report
「The stock options are linked to the company's business performance and share value. They were introduced with the approval of the annual general meeting of shareholders held on 26 June 2009, with the aim of enhancing directors' motivation and morale to contribute to sustained improvements in business performance and corporate value over the medium to long term by sharing with shareholders not only the benefits of a rising share price but also the risks of a decline.」
The stock options are linked to business performance and share value, creating a structure in which the risks of a share-price decline are also shared with shareholders.